(Q42454105)

English

A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors

scientific article published on 12 February 2014

Statements

A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors (English)
Christian P Turtschi
John Sarantopoulos
Devalingam Mahalingam

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit